Overview
TOVX market data
Price History
TOVX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.96 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.13 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.16 – $0.86 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $9.9 · P/B 0.46 · P/S 33.13.
Company News
Theriva Biologics Receives Spanish Agency Of Medicines And Medical Devices Authorization To Initiate Its VIRAGE2 Clinical TrialBenzinga · Jul 7, 2026, 12:15 PM
8-K filing — Theriva Biologics, Inc. (TOVX)SEC EDGAR · Jul 7, 2026, 12:10 PM
Theriva Biologics shares are trading higher after the company announced the publication of clinical, translational results from VCN-01's Phase 1 clinical trial in Head & Neck Squamous Cell Carcinoma in Clinical Cancer Research journal.Benzinga · Jun 11, 2026, 12:46 PM
Theriva Biologics Announces Publication Of Clinical, Translational Results From VCN-01's Phase 1 Clinical Trial In Head & Neck Squamous Cell Carcinoma In Clinical Cancer Research JournalBenzinga · Jun 11, 2026, 12:43 PM
Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer ResearchGlobenewswire Inc · Jun 11, 2026, 12:15 PM